KYORIN PHARMACEUTICAL CO., LTD. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-09-28

US20230302448A1

Performing operations; transporting

NUCLEIC ACID AMPLIFICATION CHIP

#2 | 2023-09-14

US20230285977A1

Performing operations; transporting

NUCLEIC ACID AMPLIFICATION DEVICE, NUCLEIC ACID AMPLIFICATION METHOD, AND SAMPLE SOLUTION POSITION CONTROL METHOD

#3 | 2023-03-16 ✅ Patent 12,577,217 granted on 2026-03-17

US20230082516A1

Chemistry; metallurgy

15-PGDH INHIBITOR

#4 | 2022-11-03

US20220347181A1

Human necessities

AGENT FOR TREATING NOCTURNAL POLLAKIURIA

#5 | 2022-10-20 ✅ Patent 11,952,387 granted on 2024-04-09

US20220332730A1

Chemistry; metallurgy

Bicyclic heteroaromatic ring derivative

#6 | 2022-05-12 ✅ Patent 12,351,866 granted on 2025-07-08

US20220145360A1

Chemistry; metallurgy

NUCLEIC ACID AMPLIFICATION METHOD

#7 | 2022-03-24

US20220088057A1

Human necessities

THERAPEUTIC AGENT FOR FIBROSIS

#8 | 2021-06-24 ✅ Patent 12,357,994 granted on 2025-07-15

US20210187510A1

Performing operations; transporting

PCR REACTION CONTAINER

#9 | 2021-04-15 ✅ Patent 11,261,155 granted on 2022-03-01

US20210107869A1

Chemistry; metallurgy

Urea derivative or pharmacologically acceptable salt thereof

#10 | 2021-03-25 ✅ Patent 11,326,163 granted on 2022-05-10

US20210087556A1

Chemistry; metallurgy

Therapeutic agent for fibrosis

#11 | 2021-02-25

US20210052572A1

Human necessities

RESPIRATORY INFECTION TREATING AGENT

#12 | 2021-01-07 ✅ Patent 11,376,253 granted on 2022-07-05

US20210000831A1

Human necessities

Agent for treating nocturnal pollakiuria

#13 | 2020-07-30

US20200237745A1

Human necessities

AQUEOUS DRUG

#14 | 2020-05-21 ✅ Patent 11,781,181 granted on 2023-10-10

US20200157607A1

Chemistry; metallurgy

Nucleic acid amplification device, nucleic acid amplification method, and chip for nucleic acid amplification

#15 | 2019-03-14 ✅ Patent 10,918,634 granted on 2021-02-16

US20190076421A1

Human necessities

Respiratory infection treating agent

#16 | 2018-12-06 ✅ Patent 10,517,851 granted on 2019-12-31

US20180344700A1

Human necessities

Vasopressin-like action enhancer

#17 | 2018-10-11 ✅ Patent 10,252,992 granted on 2019-04-09

US20180290974A1

Chemistry; metallurgy

Urea derivative or pharmacologically acceptable salt thereof

#18 | 2018-07-26 ✅ Patent 10,858,314 granted on 2020-12-08

US20180208552A1

Chemistry; metallurgy

Urea derivative or pharmacologically acceptable salt thereof

#19 | 2018-07-26 ✅ Patent 10,525,058 granted on 2020-01-07

US20180207153A1

Human necessities

Urea derivative or pharmacologically acceptable salt thereof

#20 | 2018-06-21 ✅ Patent 10,206,917 granted on 2019-02-19

US20180169088A1

Human necessities

Aqueous drug

#21 | 2018-06-07 ✅ Patent 10,617,684 granted on 2020-04-14

US20180153875A1

Human necessities

Aqueous drug

#22 | 2018-05-31 ✅ Patent 10,406,149 granted on 2019-09-10

US20180147199A1

Human necessities

Aqueous liquid formulation

#23 | 2018-02-15 ✅ Patent 10,029,983 granted on 2018-07-24

US20180044290A1

Chemistry; metallurgy

Urea derivative or pharmacologically acceptable salt thereof

#24 | 2018-02-15

US20180042918A1

Human necessities

RESPIRATORY INFECTION TREATING AGENT

#25 | 2017-11-09 ✅ Patent 10,154,993 granted on 2018-12-18

US20170319571A1

Human necessities

Solid pharmaceutical composition

#26 | 2017-08-31

US20170246160A1

Human necessities

SOLID PHARMACEUTICAL COMPOSITION

#27 | 2017-05-11 ✅ Patent 11,098,347 granted on 2021-08-24

US20170130261A1

Chemistry; metallurgy

Nucleic acid amplification device, nucleic acid amplification method, and chip for nucleic acid amplification

#28 | 2017-03-09 ✅ Patent 9,822,069 granted on 2017-11-21

US20170066718A1

Chemistry; metallurgy

Urea derivative or pharmacologically acceptable salt thereof

#29 | 2016-03-17 ✅ Patent 9,687,453 granted on 2017-06-27

US20160074330A1

Human necessities

Solid pharmaceutical composition

#30 | 2016-03-10 ✅ Patent 9,603,804 granted on 2017-03-28

US20160067185A1

Human necessities

Solid pharmaceutical composition

#31 | 2015-10-08 ✅ Patent 9,328,089 granted on 2016-05-03

US20150284361A1

Chemistry; metallurgy

7-{(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-YL}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal

#32 | 2015-05-07 ✅ Patent 9,863,955 granted on 2018-01-09

US20150126387A1

Physics

AMPK activator screening method, and AMPK activator

#33 | 2015-04-16 ✅ Patent 9,452,977 granted on 2016-09-27

US20150105581A1

Chemistry; metallurgy

Cyclopentylacrylamide derivative

#34 | 2015-03-12 ✅ Patent 9,315,453 granted on 2016-04-19

US20150073178A1

Chemistry; metallurgy

4-(3-benzyloxyphenylthio)-2-chloro-1-(3-nitropropyl)benzene crystal

#35 | 2014-11-20 ✅ Patent 9,216,163 granted on 2015-12-22

US20140343149A1

Human necessities

Method of inhibiting angiogenesis

#36 | 2014-09-25 ✅ Patent 9,090,587 granted on 2015-07-28

US20140288310A1

Chemistry; metallurgy

7-{(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluorodethyl)-acid crystal

#37 | 2014-08-28

US20140243302A1

Human necessities

BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

#38 | 2014-07-10 ✅ Patent 9,164,075 granted on 2015-10-20

US20140193847A1

Physics

Glutathione alkylester isotopologue and method for detecting reactive metabolite

#39 | 2014-02-13 ✅ Patent 9,382,250 granted on 2016-07-05

US20140045824A1

Chemistry; metallurgy

Method for producing complex crystal and method for screening complex crystal

#40 | 2014-01-16 ✅ Patent 8,796,247 granted on 2014-08-05

US20140018335A1

Chemistry; metallurgy

Indole derivative, and pharmacologically acceptable salt thereof

#41 | 2014-01-02 ✅ Patent 8,901,112 granted on 2014-12-02

US20140005184A1

Chemistry; metallurgy

Spirocyclic aminoquinolones as GSK-3 inhibitors

#42 | 2013-11-28 ✅ Patent 8,815,903 granted on 2014-08-26

US20130317065A1

Human necessities

Indole derivative and pharmacologically acceptable salt thereof

#43 | 2013-10-03 ✅ Patent 8,993,543 granted on 2015-03-31

US20130261089A1

Chemistry; metallurgy

Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient

#44 | 2013-08-22 ✅ Patent 9,108,915 granted on 2015-08-18

US20130217893A1

Chemistry; metallurgy

Method for producing 3,4-disubstituted pyrrolidine derivative

#45 | 2013-06-06

US20130143913A1

Human necessities

PROPHYLACTIC OR THERAPEUTIC AGENT FOR NON-ALCOHOLIC STEATOHEPATITIS

#46 | 2013-04-04 ✅ Patent 8,501,965 granted on 2013-08-06

US20130085282A1

Chemistry; metallurgy

Method for producing 3-substituted-4-fluoropyrrolidine derivative

#47 | 2012-09-13 ✅ Patent 8,710,024 granted on 2014-04-29

US20120232128A1

Chemistry; metallurgy

Treatment of influenza

#48 | 2012-04-26 ✅ Patent 8,569,270 granted on 2013-10-29

US20120101068A1

Human necessities

Diphenyl sulfide derivatives and medicines containing same as active ingredient

#49 | 2012-04-26

US20120100212A1

Human necessities

TABLET HAVING HOLLOW STRUCTURE

#50 | 2012-02-02

US20120029032A1

Human necessities

MATRIX-TYPE SUSTAINED RELEASE PREPARATION CONTAINING BASIC ADDITIVE

#51 | 2011-07-14 ✅ Patent 8,389,514 granted on 2013-03-05

US20110172219A1

Chemistry; metallurgy

Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors

#52 | 2011-06-30 ✅ Patent 8,946,440 granted on 2015-02-03

US20110160211A1

Chemistry; metallurgy

Cyclopentylacrylamide derivative

#53 | 2011-06-09 ✅ Patent 8,476,470 granted on 2013-07-02

US20110137070A1

Chemistry; metallurgy

Process for production of bicyclo[2.2.2]octylamine derivative

#54 | 2011-03-31

US20110077427A1

Chemistry; metallurgy

METHOD FOR PRODUCING OPTICALLY ACTIVE AMINOALCOHOL DERIVATIVE

#55 | 2011-03-24

US20110071204A1

Human necessities

PERCUTANEOUS ABSORPTION PREPARATION

#56 | 2011-02-17 ✅ Patent 8,404,710 granted on 2013-03-26

US20110039882A1

Human necessities

Phosphodiesterase 10A inhibitor

#57 | 2011-02-10 ✅ Patent 8,476,261 granted on 2013-07-02

US20110034436A1

Chemistry; metallurgy

Spirocyclic aminoquinolones as GSK-3 inhibitors

#58 | 2011-01-27 ✅ Patent 9,493,410 granted on 2016-11-15

US20110021636A1

Chemistry; metallurgy

Method for crystallization of 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-ethyl]-1,3-propanediol hydrochloride

#59 | 2011-01-06

US20110002988A1

Human necessities

ORALLY RAPIDLY DISINTEGRATING TABLET COMPRISING IMIDAFENACIN

#60 | 2010-12-23

US20100324081A1

Chemistry; metallurgy

PREVENTIVE, INHIBITOR OR REMEDY FOR CEREBRAL ANEURYSM COMPRISING IBUDILAST AS AN ACTIVE INGREDIENT

#61 | 2010-12-23 ✅ Patent 8,476,305 granted on 2013-07-02

US20100324057A1

Human necessities

Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient

#62 | 2010-12-23 ✅ Patent 8,722,133 granted on 2014-05-13

US20100323090A1

Human necessities

Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient

#63 | 2010-12-02 ✅ Patent 8,343,544 granted on 2013-01-01

US20100305179A1

Human necessities

Oral sustained-release tablet

#64 | 2010-11-04 ✅ Patent 8,198,256 granted on 2012-06-12

US20100280096A1

Chemistry; metallurgy

Treatment of influenza

#65 | 2010-09-16 ✅ Patent 8,071,591 granted on 2011-12-06

US20100234367A1

Chemistry; metallurgy

7-cycloalkylaminoquinolones as GSK-3 inhibitors

#66 | 2010-08-05 ✅ Patent 8,222,407 granted on 2012-07-17

US20100197909A1

Chemistry; metallurgy

Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position

#67 | 2010-04-29 ✅ Patent 8,202,456 granted on 2012-06-19

US20100102474A1

Human necessities

Method for preparing sustained release tablet

#68 | 2010-04-22 ✅ Patent 8,143,427 granted on 2012-03-27

US20100099892A1

Chemistry; metallurgy

Method for producing aminoacetylpyrrolidinecarbonitrile derivative

#69 | 2010-04-22 ✅ Patent 8,034,819 granted on 2011-10-11

US20100099671A1

Chemistry; metallurgy

Glucokinase activator

#70 | 2010-04-22 ✅ Patent 7,807,854 granted on 2010-10-05

US20100099606A1

Human necessities

Effective use method of medicaments and method of preventing expression of side effect

#71 | 2010-04-15 ✅ Patent 8,053,465 granted on 2011-11-08

US20100093825A1

Chemistry; metallurgy

Bicycloester derivative

#72 | 2010-03-04 ✅ Patent 8,084,622 granted on 2011-12-27

US20100056805A1

Chemistry; metallurgy

Process for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof

#73 | 2010-01-21 ✅ Patent 8,173,649 granted on 2012-05-08

US20100016304A1

Chemistry; metallurgy

Glucokinase activator

#74 | 2010-01-14 ✅ Patent 8,273,748 granted on 2012-09-25

US20100010000A1

Chemistry; metallurgy

Amino alcohol derivative and immunosuppresive agent having same as an active ingredient

#75 | 2009-12-31 ✅ Patent 8,232,319 granted on 2012-07-31

US20090325907A1

Chemistry; metallurgy

Amino phosphate derivative and S1P receptor modulator having same as an active ingredient

#76 | 2009-12-03 ✅ Patent 7,868,183 granted on 2011-01-11

US20090299075A1

Chemistry; metallurgy

Process for producing muscarine receptor antagonist and intermediate therefor

#77 | 2009-10-08 ✅ Patent 8,048,928 granted on 2011-11-01

US20090253802A1

Human necessities

Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease

#78 | 2009-07-09 ✅ Patent 8,106,072 granted on 2012-01-31

US20090176824A1

Chemistry; metallurgy

7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative

#79 | 2009-06-18 ✅ Patent 7,763,752 granted on 2010-07-27

US20090156653A1

Chemistry; metallurgy

Amino alcohol derivatives, salts thereof and immunosuppresive agents

#80 | 2009-05-28 ✅ Patent 8,318,811 granted on 2012-11-27

US20090137685A1

Human necessities

Method for treating an inflammatory bowel disease using 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propanediol or a salt thereof

#81 | 2009-01-22 ✅ Patent 7,667,049 granted on 2010-02-23

US20090023935A1

Chemistry; metallurgy

Process for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof

#82 | 2008-11-06 ✅ Patent 7,759,326 granted on 2010-07-20

US20080275008A1

Chemistry; metallurgy

Aminophosphonic acid derivative, salt thereof, and modulator of S1P receptor

#83 | 2008-08-28 ✅ Patent 7,795,472 granted on 2010-09-14

US20080207941A1

Chemistry; metallurgy

Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride and hydrates thereof, and intermediates in the production thereof

#84 | 2008-08-28 ✅ Patent 7,763,617 granted on 2010-07-27

US20080207902A1

Chemistry; metallurgy

Pyrazolopyridine-4-yl pyridazinone derivatives and addition salts thereof, and PDE inhibitors comprising the same derivatives or salts as active ingredient

#85 | 2008-07-03 ✅ Patent 7,879,846 granted on 2011-02-01